Gene Expression in Pancreatic Cancer

Inclusion Criteria

• •1. Male or female, aged 18 years or above
• •2. Patients with pancreatic cancer planned for surgical resection, or patients with locally advanced or metastatic pancreatic cancer
• •3. For patients planned for resection the tumour must be within the head of the pancreas such that the EUS biopsy sites and needle track can be resected surgically
• •4. Adequate blood clotting parameters in order to undergo an EUS with biopsies, evidenced by the following:
• •1. Platelet count ≥ 75 x 109L
• •2. International normalised ratio (INR) ≤ 1.5
• •5. Patients have given written informed consent and are willing and able to comply with the scheduled visits, laboratory tests and study procedures including endoscopy (e.g. patients able to lie flat without being breathless and have no evidence of oesophageal stricture)